NMRA resumes price controls; 350 drug prices reduced

The National Medicines Regulatory Authority (NMRA) has reduced the prices of 350 medicines used for a range of conditions including childhood illnesses, cancer, diabetes and hypertension, its Chairman, Consultant Physician Dr. Ananda Wijewickrama said today. He announced the move during a media briefing held at the Government Information Department, noting that the price revisions follow the new gazette issued by Health and Mass Media Minister Dr. Nalinda Jayatissa and later approved by Parliament. Dr. Wijewickrama said the NMRA has the legal authority under the National Medicines Regulatory Authority Act No. 5 of 2015 to regulate medicine prices. However, price controls…

Read the full article →